SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
Por um escritor misterioso
Descrição
Abstract Pilomatricomas are benign tumors originating from the capillary matrix, which may
Population pharmacokinetics and exposure–response of selumetinib and its N‐desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US
CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome, Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome,
American Journal of Hematology, Blood Research Journal
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome, Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome,
Targeted two-photon chemical apoptotic ablation of defined cell types in vivo
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial - The Lancet Neurology
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial - The Lancet Neurology
SciELO - Brasil - New proteasome inhibitors in the treatment of multiple myeloma New proteasome inhibitors in the treatment of multiple myeloma
de
por adulto (o preço varia de acordo com o tamanho do grupo)
